PancChat Podcast with Alisyn Camerota

The PancChat Podcast is a collaborative effort from Let’s Win Pancreatic Cancer and the Pancreatic Cancer Action Network (PanCAN), inspired by the long-running #PancChat Twitter/X chat. Hosted by award-winning journalist Alisyn Camerota, each episode features conversations with leading researchers, clinicians, patients, and advocates who are shaping the future of pancreatic cancer care and research. Together, we deliver expert insights, personal journeys, and the latest breakthroughs—bridging the gap between science and lived experience. Whether you’re a patient, caregiver, healthcare professional, or simply want to learn more, join us to connect, be inspired, and learn how you can help to accelerate progress in the fight against pancreatic cancer.

PancChat Podcast with Alisyn Camerota is a business podcast hosted by Unknown Host, with 27 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts PancChat Podcast with Alisyn Camerota, a business show with 27 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #27

  The Link Between Diabetes and Pancreatic Cancer

  Aug 13, 202623 min

  Almost one in four people diagnosed with pancreatic cancer are also diagnosed with diabetes. In this episode of PancChat, host Alisyn Camerota talks with Dr. Suresh Chari, professor of medicine at MD Anderson Cancer Center and principal investigator for the PanCAN Early Detection Initiative, about the complex relationship between diabetes and pancreatic cancer. Dr. Chari explains why new-onset diabetes can be an early warning sign for pancreatic cancer, why a sudden rise in blood sugar alongside unexplained weight loss is a pattern worth watching, and why early detection remains one of the biggest challenges in pancreatic cancer research. He also shares an update on the clinical trials underway — including AI-assisted imaging — aimed at catching pancreatic cancer earlier in people with new-onset diabetes. This episode is sponsored by Revolution Medicines. To learn more about pancreatic cancer support and resources, visit letswinpc.org and pancan.org . Resources: Let's Win Diabetes Info PanCAN Diabetes Info Let's Win Diabetes and Pancreatic Cancer Awareness Risk Quiz PanCAN Patient Services The Diabetes and Pancreatic Cancer Connection

  ListenShow Notes
• 

  Episode #26

  Emerging Trials in Pancreatic Cancer

  Jul 28, 202623 min

  With one new drug against the KRAS mutation on the path to FDA approval, what is the status of other KRAS drugs, as well as different types of treatment? To get the latest information, host Alisyn Camerota is joined once again by Dr. Allyson Ocean, medical oncologist and director of the Pancreatic Cancer Research Program at Weill Cornell Medicine, and a co-founder of Let's Win, along with Dr. Anna Berkenblit, Chief Scientific and Medical Officer for PanCAN, who brings more than two decades of experience in the research and clinical development of novel anticancer therapies. Together, they discuss the status of pancreatic cancer vaccine research, walk through what a drug's journey from idea to approval actually looks like, and explain in plain terms what separates a phase 1 clinical trial from a phase 2 or phase 3 trial — and why every phase matters for patients considering enrollment. This episode is brought to you by our sponsor, Revolution Medicines. To learn more about the latest breakthroughs in pancreatic cancer treatment, visit letswinpc.org and pancan.org. PancChat is produced in collaboration with Let's Win Pancreatic Cancer and PanCAN.

  ListenShow Notes
• 

  Episode #25

  Advancements This Year

  Jul 14, 202629 min

  New pancreatic cancer treatments have not been approved in many years, but the first half of 2026 has seen some significant treatment advances. In this episode, host Alisyn Camerota talks with Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer, and Dr. Allyson Ocean, director of the pancreatic cancer research program at Weill Cornell Medicine and co-founder of Let's Win Pancreatic Cancer, about what's changing and what it means for patients. Dr. Berkenblit and Dr. Ocean discuss the phase 3 results for daraxonrasib, a RAS-targeted therapy now available to some patients through an FDA expanded access program. They also cover the broader pipeline of RAS inhibitors and degraders in development, progress on personalized and off-the-shelf pancreatic cancer vaccines, and tumor-treating fields (TTF)—brand-name Optune Pax—a newly approved device-based therapy for locally advanced disease. Dr. Berkenblit and Dr. Ocean also focus on what these developments mean for patients navigating treatment decisions today, and why clinical trial participation remains central to progress in the field. Thank you to our sponsor, Revolution Medicines. Learn more at letswinpc.org and pancan.org . Resources: PanCAN Patient Services Let’s Win Doctor Finder PanCAN Clinical Trial Finder Let’s Win Clinical Trial Finder Accessing Daraxonrasib: A Quick Primer PancChat is produced in collaboration with Let's Win Pancreatic Cancer and PanCAN.

  ListenShow Notes
• 

  Episode #24

  Surviving Pancreatic Cancer

  Jun 30, 202631 min

  Roberta Luna is a 24-year pancreatic cancer survivor. When she was diagnosed in 2002, her doctors gave her months to live. But she was determined that the same disease that had already taken her father and uncle would not take her. In this episode, Roberta talks with host Alisyn Camerota about navigating a stage three diagnosis, the role of clinical trials, the diet and lifestyle changes she credits with her health, and the survivor's guilt that comes with outliving a prognosis. She also shares why she's never made a bucket list — and why she jumps out of a plane every April instead. Listen to this conversation about hope, advocacy, and finding your "why." PancChat is a collaboration between Let's Win Pancreatic Cancer and PanCAN , sponsored by Revolution Medicines.

  ListenShow Notes
• 

  Episode #23

  Living with Pancreatic Cancer

  Jun 22, 202625 min

  What is it like to live with pancreatic cancer?. Randi Ervin was diagnosed with a pancreatic neuroendocrine tumor (PNET) in her 30s. Even after a total pancreatectomy she remains in treatment to keep the tumor in check. In the years since her diagnosis she has become an insulin-dependent diabetic, lost her mother to pancreatic cancer, and built a full life as a health equity advocate and volunteer with PanCAN's Survivor Council and Health Equity Committee. In this episode, host Alisyn Camerota talks with Randi about what survivorship actually looks like a decade out — the monthly octreotide injections, the annual DOTATATE scans, the diabetes management, and the emotional weight of being both a patient and a caregiver. They also discuss why sharing your diagnosis with a wider circle can matter, how health equity shapes who gets to access good care, and why the five-year mark is not, in fact, the finish line. For more survivor stories, visit letswinpc.org. For patient services and support, visit pancan.org. PancChat is produced in collaboration with Let's Win Pancreatic Cancer and PanCAN. PancChat sponsored by Revolution Medicines.

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.